Engineering the Human Fc Region Enables Direct Cell Killing by Cancer Glycan-Targeting Antibodies without the Need for Immune Effector Cells or Complement (2020)
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1158/0008-5472.can-19-3599
PubMed Identifier: 32532823
Publication URI: http://europepmc.org/abstract/MED/32532823
Type: Journal Article/Review
Parent Publication: Cancer Research
Issue: 16
ISSN: 0008-5472